Publications

Found 295 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2023
Mathios D, Joshua S, Bobeff EJ, Mistry AA, Schwartz AC, Dobri GA, Tabaee A, Kacker A, Anand VK, Schwartz TH.  2023.  Durable headache relief following endoscopic endonasal resection of sub-centimeter Rathke cleft cysts in medically refractory patients.. Acta Neurochir (Wien).
Rezai AR, Ranjan M, Haut MW, Carpenter J, D'Haese P-F, Mehta RI, Najib U, Wang P, Claassen DO, J Chazen L et al..  2023.  Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.. J Neurosurg. 139(1):275-283.
Mathios D, Bobeff EJ, Longo D, Nilchian P, Estin J, Schwartz AC, Austria Q, Anand VK, Godfrey KJ, Schwartz TH.  2023.  The lateral transorbital approach to the medial sphenoid wing, anterior clinoid, middle fossa, cavernous sinus, and Meckel's cave: target-based classification, approach-related complications, and intermediate-term ocular outcomes.. J Neurosurg. :1-11.
Mathios D, Bobeff EJ, Longo D, Nilchian P, Estin J, Schwartz AC, Austria Q, Anand VK, Godfrey KJ, Schwartz TH.  2023.  The lateral transorbital approach to the medial sphenoid wing, anterior clinoid, middle fossa, cavernous sinus, and Meckel's cave: target-based classification, approach-related complications, and intermediate-term ocular outcomes.. J Neurosurg. :1-11.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Bobeff EJ, Mathios D, Mistry AA, Dobri GA, Souweidane MM, Anand VK, Tabaee A, Kacker A, Greenfield JP, Schwartz TH.  2023.  Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma.. J Neurosurg. 139(5):1235-1246.
2022
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Valenti AB, Asadourian P, Guadix S, Truong AY, Buontempo M, Hoffman CE, Souweidane M, Imahiyerobo TA.  2022.  Management of Total Frontal Bone Loss After Surgery for Craniosynostosis: The Modified Visor Bone Flap With Brain Cage.. Cleft Palate Craniofac J. :10556656221121041.
Miller AM, Szalontay L, Bouvier N, Hill K, Ahmad H, Rafailov J, Lee AJ, M Rodriguez-Sanchez I, Yildirim O, Patel A et al..  2022.  Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.. Neuro Oncol.
Miller AM, Szalontay L, Bouvier N, Hill K, Ahmad H, Rafailov J, Lee AJ, M Rodriguez-Sanchez I, Yildirim O, Patel A et al..  2022.  Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.. Neuro Oncol.
Niemeyer JE, Gadamsetty P, Chun C, Sylvester S, Lucas JP, Ma H, Schwartz TH, Aksay ERF.  2022.  Seizures initiate in zones of relative hyperexcitation in a zebrafish epilepsy model.. Brain.
2021
Guadix SW, Tao AJ, An A, Demetres M, Tosi U, Chidambaram S, Knisely JPS, Ramakrishna R, Pannullo SC.  2021.  Assessing the long-term safety and efficacy of gamma knife and linear accelerator radiosurgery for vestibular schwannoma: A systematic review and meta-analysis.. Neurooncol Pract. 8(6):639-651.
Bander ED, Sherman JH, Bettegowda C, Aghi MK, Sheehan J, Ramakrishna R.  2021.  Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons.. J Neurooncol. 151(3):361-366.
Cho W, Auerbach JD, K Riew D.  2021.  Crossing the Cervico-Thoracic Junction in Long Posterior Cervical Fusions Reduces Caudal Adjacent Segment Pathology.. Global Spine J. :2192568220984470.
Yahanda AT, P Adelson D, S Akbari HA, Albert GW, Aldana PR, Alden TD, Anderson RCE, Bauer DF, Bethel-Anderson T, Brockmeyer DL et al..  2021.  Dural augmentation approaches and complication rates after posterior fossa decompression for Chiari I malformation and syringomyelia: a Park-Reeves Syringomyelia Research Consortium study.. J Neurosurg Pediatr. :1-10.
Yahanda AT, P Adelson D, S Akbari HA, Albert GW, Aldana PR, Alden TD, Anderson RCE, Bauer DF, Bethel-Anderson T, Brockmeyer DL et al..  2021.  Dural augmentation approaches and complication rates after posterior fossa decompression for Chiari I malformation and syringomyelia: a Park-Reeves Syringomyelia Research Consortium study.. J Neurosurg Pediatr. :1-10.
Yahanda AT, P Adelson D, S Akbari HA, Albert GW, Aldana PR, Alden TD, Anderson RCE, Bauer DF, Bethel-Anderson T, Brockmeyer DL et al..  2021.  Dural augmentation approaches and complication rates after posterior fossa decompression for Chiari I malformation and syringomyelia: a Park-Reeves Syringomyelia Research Consortium study.. J Neurosurg Pediatr. :1-10.